πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8338366

Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

The Board of Regents of the University of Texas System Β· Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8334259

Method of treating endothelial dysfunction comprising administration of a thrombin peptide

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8334239

High affinity VEGF-receptor antagonists

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8328785

Use of nanoparticles in the photodynamic treatment of tumors

The Board of Regents of the University of Texas System Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8329745

Small molecule inhibitors of ghrelin O-acyltransferase

The Board of Regents of the University of Texas System Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8329141

Locoregional internal radionuclide ablation of abnormal tissues

The Board of Regents of the University of Texas System Β· Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8324181

Modulation of gene expression by oligomers targeted to chromosomal DNA

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8323962

Molecules with extended half-lives, compositions and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8323906

Compositions, kits, and methods for identification, assessment, prevention and therapy of

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8323665

Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolize

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8318951

Stem cell differentiating agents and uses therefor

The Board of Regents of the University of Texas System Β· Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8309595

Hydrazone modulators of cannabinoid receptors

The Board of Regents of the University of Texas System Β· Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8304247

Recognitive hydrogel

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8304526

Antitumor effect of mutant Bik

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8304399

Hedgehog signaling pathway proteins and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8304397

Identification of a micro-RNA that activates expression of Ξ²-myosin heavy chain

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8303995

Nitrite formulations and their use as nitric oxide prodrugs

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298542

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequen

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8299040

Methods for treating cancer targeting transglutaminase

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8299033

Iodo-hexose compounds useful to treat cancer

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8298589

Nitrite formulations and their use as nitric oxide prodrugs

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8283458

VMP-like sequences of pathogenic Borrelia species and strains

The Board of Regents of the University of Texas System Β· Granted Tue Oct 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273729

Treatment of irritable bowel syndrome and related bowel disease

The Board of Regents of the University of Texas System Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8273746

Methods involving aldose reductase inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted